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Brief Communication
Mouse NG2 Oligodendrocyte Precursors Express mRNA for
Proteolipid Protein But Not Its DM-20 Variant: A Study of
Laser Microdissection-Captured NG2 Cells
Ping Ye,1 Robert Bagnell,2,3 and A. Joseph D’Ercole1
Departments of 1Pediatrics and 2Pathology and Laboratory Medicine and 3Microscope Service Laboratory, The University of North Carolina at Chapel Hill,
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Despite recent advances in our understanding of lineage of oligodendrocytes, detailed molecular characterization of this lineage in vivo
is limited, primarily because of our inability to obtain a pure population of cells in situ. To define the molecular characteristics of
oligodendrocyte lineage cells during development and their response to injury, we developed a strategy that uses laser capture microdis-
section (LCM) to isolate cells from sections and reverse transcription-PCR to determine mRNA expression. As a first step, we examined
the expression of myelin-specific protein genes in NG2 cells in cerebral cortex. We demonstrate that NG2 cells in both developing and
adult mice express NG2 mRNA but not mRNA for proteins specific for astrocytes, neurons, or microglia, indicating that a highly pure
population of antigen-specific cells of the oligodendrocyte lineage can be obtained using LCM. Furthermore, we show that NG2 cells
express mRNAs for proteolipid protein (PLP), myelin basic protein, and 2,3-cyclic nucleotide 3-phosphodiesterase, but they dot not
express DM-20 mRNA, a PLP mRNA splicing variant. Our data demonstrate that antigen-specific cells of oligodendrocyte lineage differ-
entially express mRNA for myelin-specific proteins and their variants in vivo, partly define the gene expression in NG2 cells, and raise
questions about the cellular sites of DM-20 expression. This work also shows that LCM is a valuable tool to define and analyze gene
expression in the cells of the oligodendrocyte lineage.
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Introduction
In the CNS, oligodendrocytes develop from glial progenitors in
the ventricular and subventricular zones (Hirano and Goldman,
1988; Levison and Goldman, 1993). Recent developments using
molecular biology and immunology techniques have made it
possible to identify cells of the oligodendrocyte lineage both in
vitro and in vivo. These studies have significantly advanced our
knowledge and led to our current understanding of oligodendro-
cyte development (for review, see Raff, 1989; Woodruff et al.,
2001). Despite these advances, detailed molecular characteriza-
tion of oligodendrocyte lineage cells in vivo during development
and after injury is limited, primarily because of our inability to
obtain pure populations of cell types in situ. For example,
whereas the expression of genes encoding for myelin-specific
proteins has been well studied in developing CNS using Northern
blot hybridization, RNA protection assay, reverse transcription
(RT)-PCR, and Western immunoblot analyses (Morell et al.,
1972; Lai et al., 1987; Schindler et al., 1990; Inuzuka et al., 1991;
Pedraza et al., 1991), these studies used whole brain or brain
regions, making it impossible to identify the cellular origin for
each myelin-associated protein. In situ mRNA hybridization
analysis, immunohistochemical staining, and combined in situ
hybridization and immunostaining also have provided impor-
tant information about cellular expression of myelin-specific
proteins. The unavailability of isoform-specific probes or anti-
bodies, however, has made it difficult to precisely identify the
oligodendrocyte lineage cells that express each isoform of the
myelin-specific protein genes.
To define the pattern of gene expression in the cells of the
oligodendrocyte lineage during development and after injury, we
developed a strategy that uses laser capture microdissection
(LCM) to remove cells from sections. This allows isolation of
RNA from defined in vivo cell populations and use of RT-PCR to
precisely identify the mRNAs that they express. Here we report
the expression of myelin protein genes in NG2 immunopositive
(NG2) cells in the cerebral cortex (CTX). We provide evidence
that the NG2 cells express mRNAs for proteolipid protein
(PLP), MBP, and 2,3-cyclic nucleotide 3-phosphodiesterase
(CNP) but not the mRNA for DM-20, a PLP mRNA splicing
variant. Our data indicate that NG2  cells are a unique pop-
ulation of cells in the oligodendrocyte lineage and that LCM is
a valuable tool for defining and analyzing the molecular char-
acteristics of antigen-specific cells in oligodendrocyte lineage
in vivo.
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Materials and Methods
Tissue collection. Under deep anesthesia, brains of mice (C57BL/6) were
removed and collected. For whole CTX RNA extraction, CTX were dis-
sected (n  3) and frozen in liquid nitrogen. For immunohistochemistry
and LCM, brains (n  3) were split near the middle sagittal line, frozen in
liquid nitrogen, and sagittally sectioned at a thickness of 8 m on a
cryostat. Both sections and CTX were stored at 80°C until use. All
procedures used were approved by the institutional review committee of
the University of North Carolina at Chapel Hill.
Immunohistochemistry and cell capture. After thawing at room temper-
ature briefly, sections near the midsagittal line were fixed with 75% eth-
anol for 20 sec and washed with PBS. In the presence of RNase inhibitor
(200 U/ml; Promega, Madison, WI), the sections were immunostained
for NG2  cells for 30 min using an anti-NG2 antibody (1:400; a gift from
Dr. Bill Stallcup, The Burnham Institute, La Jolla, CA). Antibody–anti-
gen complexes were detected using peroxidase-conjugated polymers and
visualized by incubation with DAB, provided in an EnVision immu-
nostaining system (Dakocytomation; Dako, Carpinteria, CA).
After sections were dehydrated via a gradient concentration of ethanol,
NG2  cells (250 –500) were microdissected and captured from two sec-
tions using a PixCell laser capture microdissector (Arcturus Engineering,
Santa Clara, CA). Individual samples (250 –500 NG2  cells) derived
from each brain were then transferred to a microcentrifuge tube contain-
ing 10 l of cell lysis buffer provided in an RNA PicoPure kit (Arcturus
Engineering).
Total RNA isolation and RT-PCR. Total RNA from NG2  cells cap-
tured with LCM was extracted using the RNA PicoPure kit according the
protocol of the manufacturer. Resultant RNA was dissolved in 10 l of
H2O and subjected to RT-PCR. Whole CTX RNA was isolated using the
acidic guanidinium thiocyanate–phenol– chloroform method (Chom-
czynski and Sacchi, 1987) and subjected to RT-PCR. RT was performed
using Supercript II reverse transcriptase (Invitrogen, Carlsbad, CA), a 27
base poly deoxythymidine primer, and 10 l of RNA derived from NG2 
cells or 10 g of CTX RNA. The resultant cDNA (1 l of RT reaction
derived from CTX RNA and 2.5 l of RT reaction derived from LCM-
captured NG2  RNA, respectively) was then used as template for PCR
amplification (40 cycles, in a 25 l reaction volume), using specific 20 base
oligonucleotide primers. Primers used for PLP–DM-20 amplification were
5-gaaaagctaattgagaccta-3 (forward) and 5-gagcagggaaactagtgtgg-3 (re-
verse). The sequences of each primer used and the primer positions for
myelin-specific protein genes are provided as supplemental materials at
http://www.unc.edu/pye1/Table1.htm. PCR-amplified DNA fragments
were resolved on 1% agarose gel containing ethidium bromide and then
photographed. For each gene, the primer pairs are identical or complimen-
tary to sequences that span multiple exons. This strategy allowed amplifica-
tion of mRNA encoded by several exons, and, therefore, PCR products de-
rived from splicing mRNA variants could be readily identified by size. In
addition, this method ensured that the cDNAs obtained could not have been
amplified from contaminating genomic DNA [the large DNA intron seg-
ment(s) between exons either would not have been amplified because of
their size or would have yielded products of sizes that could easily be discrim-
inated from their mRNAs].
Sequence of cDNA derived from RT-PCR. PCR-amplified DNA frag-
ments were resolved on 1% agarose gel. DNA band of interest was cut out
and purified using Wizard PCR Preps DNA Purification System (Pro-
mega). DNA sequencing was performed at the Automated DNA Se-
quencing Facility at the University of North Carolina at Chapel Hill.
Southern blot hybridization analysis. PCR-amplified DNA fragments
were fractionated on 1% agarose gel, transferred onto a nylon mem-
brane, UV cross-linked, and hybridized with 32P-labeled single-stranded
DNA (ssDNA) probe. PLP DNA fragment corresponding to bp 217–903
of mouse PLP cDNA (Hudson et al., 1987) was amplified by PCR and
used as a template for hybridization probe. The 32P-labeled ssDNA probe
was generated by linear PCR using PLP 3 end primers and 32P-dCTP
(Amersham Biosciences, Arlington Heights, IL), as described previously
(Ye et al., 1992, 1995).
Results
Consistent with previous reports (Nishiyama et al., 1997; Reyn-
olds and Hardy, 1997; Diers-Fenger et al., 2001), NG2 cells in
the CTX of adult mice radially extend multiple long processes. To
obtain a high pure population of NG2 cells, soma and the por-
tions of the processes that were proximal to the cell body of each
NG2 cell were made to focally adhere to a membrane by activa-
tion with a laser beam (Fig. 1).
To confirm the identity of LCM-captured NG2 cells and to
determine whether there was contamination of captured NG2
cells with other cell types, we used RT-PCR to examine the ex-
pression of mRNA derived from LCM-captured NG2 cells de-
rived from 4-month-old mice for the following cell-specific pro-
teins: NG2, glial fibrillary acidic protein (GFAP)(astrocytes),
CD68 (microglia–macrophages), and neurofilament light-
subunit (NF-L) (neurons). Total RNA derived from whole CTX
was used in parallel RT-PCR reactions. When CTX RNA was
used, a single DNA band of the expected size was observed for
Figure 1. Representative microphotographs of a cerebral cortical section stained for NG2 
precursors derived from a 4-month-old mouse before ( A) and after ( B) LCM, as well as that of
the same captured cells on a membrane ( C). Arrows in A indicate NG2  cells. Note that these
cells are absent in B.
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each NG2, GFAP, CD68, and NF-L mRNA, respectively (Fig. 2).
In contrast, only NG2 mRNA was detected in the LCM-captured
cortical NG2 cells, and no mRNA for GFAP, CD68, or NF-L
mRNA was detected. These data show that LCM can be used to
obtain NG2 cells with little or no contamination of other CNS
cell types.
Next, we examined the expression of mRNAs for the four
major myelin-specific proteins: PLP, MBP, myelin-associated
glycoprotein (MAG), and CNP in NG2 cells. RNA derived from
CTX of adult mice was again used as a control. mRNAs for all four
myelin-specific proteins were detected in CTX RNA. As expected,
multiple splicing forms of PLP, MBP, and MAG mRNA were
clearly distinguished. As Figure 3A shows, two PLP bands of 582
and 687 bp representing DM-20 and PLP mRNA, respectively,
were evident. Similarly, three MBP bands of 354, 422– 442, and
479 bp (representing mRNA coded for 14, 17, or 18.5 kDa MBP,
respectively) and two MAG bands 343 and 388 bp (coding for
the large and small forms of MAG, MAG-L and MAG-S, respec-
tively) were detected. Among these mRNA variants of each mye-
lin protein gene, mRNA coding for 14 kDa MBP, PLP, and
MAG-S was the most abundant, a finding consistent with previ-
ous studies showing that 14 kDa MBP, PLP, and MAG-S proteins
and their mRNAs are predominately expressed in the CNS of
adult mice (Morell et al., 1972; Lai et al., 1987; Campagnoni et al.,
1989; Fujita et al., 1989; Schindler et al., 1990; Pedraza et al., 1991;
Ikenaka et al., 1992).
When RNA derived from LCM NG2 cells was used, PLP and
MBP mRNAs also were readily detected (Fig. 3A). RT-PCR am-
plification also identified a single faint CNP band and MAG
bands. The MAG bands, although clearly visible on the gel under
UV light, did not photograph well in Figure 3. In contrast to CTX
RNA, which contained both PLP and DM-20 mRNAs, LCM
NG2 cells exhibited only one RT-PCR-amplified DNA band at
687 bp (i.e., the smaller 582 bp DM-20 band was not observed).
To be certain that the 687 bp DNA band in LCM samples was
derived from PLP mRNA, the DNA band was sequenced after gel
purification. DNA sequencing data confirmed that the 687 bp
band derived from isolated NG2 cells corresponded to PLP
mRNA (data not shown).
Three MBP 354, 422– 442, and 479 bp bands (corresponding
to MBP mRNA splicing variants coding for 14, 17, and 18.5 kDa
proteins, respectively) also were observed in RNA from NG2
cells. Unlike adult CTX that expresses predominately mRNA en-
coded for 14 kDa MBP, however, mRNA for 18.5 kDa MBP (the
479 bp band) was the most abundant form in NG2 cells.
DM-20 mRNA has been shown to be the predominant form of
the two PLP isoforms during early development (Morell et al.,
1972; Schindler et al., 1990; Ikenaka et al., 1992). To determine
whether DM-20 is expressed in NG2 cells during early postnatal
development, NG2 cells were isolated from the CTX of mice at
postnatal day 5 (P5) and subjected to RT-PCR. RT-PCR exami-
nation for NG2, GFAP, CD68, and NF-L mRNAs was first per-
formed to be certain that NG2 cells were isolated with little or
no contamination of other cell types. Similar to the results ob-
tained from the NG2 cells of adult mice, only NG2 mRNA was
detected, and no GFAP, CD68, and NF-L mRNA was detected in
the NG2 cells derived from P5 mice (data not shown). Although
abundant DM-20 mRNA was observed in the P5 CTX, no DM-20
mRNA was detected in the NG2 cells in the CTX of P5 mice
(Fig. 3B).
The expression of MBP mRNA in the NG2 cells of P5 CTX
also was examined. Unlike adult CTX, which expresses predom-
inately mRNA coding 14 kDa MBP (354 bp band), mRNAs en-
coding larger MBP isoforms (17 and 18.5 kDa, i.e., the 422– 442
and 479 bp bands, respectively) were more abundant in the
NG2 cells, findings that are consistent with those that we ob-
served in RNA derived from adult NG2 cells.
To exclude the possibility that DM-20 mRNA is expressed at
low levels in NG2 cells, two rounds of PCR amplification for
PLP–DM-20 mRNA from both P5 and adult mice were per-
Figure 2. Expression of NG2, GFAP, CD68, and NF-L mRNAs in cerebral cortical NG2  cells
and whole cerebral cortex. Total RNA was isolated from LCM-captured NG2  cells (LCM) and
from whole cerebral cortex (CTX) of a 4-month-old mouse, and each RNA preparation was
subjected to RT-PCR. RT-PCR DNA products were fractionated on 1% agarose gel containing
ethidium bromide and photographed under UV light. The mRNA products derived from RT-PCR
are indicated on the top of each lane. A DNA ladder of 100 bp markers was loaded in the left lane,
and the size of the 400 and 600 bp bands are indicated by arrows. Note that the bands at bottom
of the figure are primers used for RT-PCR.
Figure 3. Expression of myelin protein mRNA in cerebral cortical NG2  cells and whole
cerebral cortex. A, Expression of PLP, CNP, MAG, and MBP mRNAs in 4-month-old mice. Total
RNA was isolated from LCM-captured NG2  cells (LCM) and from whole cerebral cortex (CTX) of
a mouse and was subjected to RT-PCR. RT-PCR DNA products were separated on 1% agarose gel.
Each mRNA product derived from RT-PCR is indicated on the top of each lane. B, Expression of
PLP–DM-20 and MBP mRNA during development. Total RNA was extracted from cerebral cor-
tical NG2  cells (LCM) and cerebral cortex (CTX) of a 5-d-old mouse (P5) and a 4-month-old
mouse (A), respectively, and subjected to RT-PCR. In both panels, DNA 100 bp markers were
loaded in the middle lane. The arrowheads on the left of the panel indicate the expected sizes for
RT-PCR amplified DNA derived from PLP (687 bp) and DM-20 (582 bp) mRNA, respectively. The
arrowheads on the right indicate the expected sizes for RT-PCR amplified DNA (479, 422, and
354 bp) derived from MBP mRNA variants, respectively.
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formed, followed by Southern blot hybridization analysis using a
32P-labeled PLP probe that hybridizes both PLP and DM-20
cDNA. In multiple experiments, we were unable to detect DM-20
mRNA in cortical NG2 cells derived from P5 or adult mice. A
representative PLP Southern hybridization blot is shown in Fig-
ure 4.
Discussion
Using LCM, we demonstrated that it is possible to isolate a pop-
ulation of NG2 cells from mouse CTX sections with little or no
contamination of microglia, astrocytes, or neurons. We showed
that NG2 cell RNA contains mRNAs specific for NG2 and sev-
eral myelin-specific proteins, including PLP and MBP, but not
mRNAs for other cell type-specific proteins, such as GFAP (as-
trocytes), NF (neurons), and CD68 (microglia). These findings
are consistent with previous data showing that NG2 cells do not
react with the antibodies specific for astrocytes, neurons, or mi-
croglia (Nishiyama et al., 1997; Reynolds and Hardy, 1997;
Keirstead et al., 1998; Diers-Fenger et al., 2001), exhibit immu-
noreactivity for PLP–DM-20, MBP, and MAG (Trapp et al.,
1997), and can drive the expression of a PLP promoter-driven
transgene (Mallon et al., 2002). Perhaps more importantly, we
demonstrated that NG2 cells of both developing and adult mice
express little or no DM-20 mRNA and that they predominately
express 17 and 18.5 kDa MBP mRNA. We believe that this is the
first demonstration that antigen-specific cells of oligodendrocyte
lineage differentially express mRNA for myelin-specific proteins
and their splicing variants in vivo. Our results also demonstrate
that LCM is an important and useful tool to define and analyze
the molecular characteristics of antigen-specific cells of the oligo-
dendrocyte lineage.
NG2 is a large cell surface proteoglycan that is expressed in the
CNS of both developing and adult rodents and humans (for re-
view, see Dawson et al., 2000). In developing rodents, NG2 cells
are widespread in the CNS, and they exhibit many characteristics
of oligodendrocyte precursors: they are either bipolar or have few
processes and, thus, morphologically resemble oligodendrocyte
precursors in culture (Nishiyama et al., 1996; Diers-Fenger et al.,
2001; Ye et al., 2002); they express oligodendrocyte precursor
markers, such as PDGFR and A2B5 in vivo and in culture (Stall-
cup and Beasley, 1987; Nishiyama et al., 1996; Reynolds and
Hardy, 1997; Keirstead et al., 1998; Diers-Fenger et al., 2001;
Mallon et al., 2002); they proliferate, as judged by their incorpo-
ration of bromodeoxyuridine (BrdU) (Mallon et al., 2002); they
possess electophysiological properties of glial progenitor cells
(Diers-Fenger et al., 2001); and they are capable of developing
into mature oligodendrocytes in vivo and in culture (Stallcup and
Beasley, 1987; Trapp et al., 1997; Diers-Fenger et al., 2001).
In adult rodents, NG2 cells also are abundant in the CNS
(Nishiyama et al., 1996; Reynolds and Hardy, 1997; Diers-Fenger
et al., 2001; Mallon et al., 2002). Unlike during development,
however, NG2 cells in adult rodent brains exhibit large cell
bodies with long complex processes (Ye et al., 2000, 2002; Diers-
Fenger et al., 2001). Despite the fact that their morphology is not
like most precursors, current data indicate that NG2 cells in
adult mice also are oligodendrocyte precursors, as shown by their
capability to incorporate BrdU and the fact that they increase in
number after injury and in response to growth factor stimulation
(Keirstead et al., 1998; Mason et al., 2000; Ye et al., 2000, 2002).
Our current data showing NG2 cells in both developing and
adult brains predominately express the 17 and 18.5 kDa MBP
isoforms, a characteristic of early developing brain, further sup-
port the hypothesis that NG2 cells are oligodendrocyte
precursors.
Our findings that PLP, but not DM-20, mRNA is detected in
NG2 oligodendrocyte precursors during development are con-
sistent with those of Mallon et al. (2002). Using a rat PLP
promoter-driven enhanced green fluorescent protein reporter
transgene, Mallon et al. demonstrated that PLP gene is actively
expressed in CNS NG2 cells of transgenic mice during develop-
ment. Our data also are in line with that of Trapp et al. (1997),
who reported that some NG2 cells colocalized with PLP–DM-
20-immunoreactive antigen in the developing rodent brain. Our
data extends the above-cited reports by demonstrating that
NG2 oligodendrocyte precursors express full-length PLP
mRNA but are not a significant site of DM-20 mRNA expression
in vivo. The latter finding raises questions about the sites of
DM-20 expression.
DM-20 mRNA and its protein, products of an alternatively
spliced PLP mRNA that lacks 105 nucleotides in the exon 3 (Nave
et al., 1987), are the major forms of PLP expressed during early
CNS development (Schindler et al., 1990; Ikenaka et al., 1992).
Schindler et al. (1990) reported that DM-20 protein is present
before PLP in fetal bovine cerebral cortex. Later, Ikenaka et al.
(1992), using combined RT-PCR and Southern blot hybridiza-
tion analysis, demonstrated that DM-20 mRNA is expressed in
the mouse CNS during embryonic development, a time when
mature oligodendrocytes are rare. It has been postulated, there-
fore, that DM-20 is the predominant PLP isoform in oligoden-
drocyte precursors. These studies, however, used whole brain or
brain regions and, thus, could not determine the cell type(s) that
Figure 4. Representative Southern blot hybridization analysis of RT-PCR amplified PLP–
DM-20. A, RT-PCR amplified PLP–DM-20 DNA fragments derived from cerebral cortical NG2 
cells (LCM) and cerebral cortex (CTX) of a 5-d-old mouse (P5) and a 4-month-old mouse (A) were
fractionated on 1% agarose gel. B, DNA fragments, fractionated on 1% agarose shown in A,
were transferred onto a nylon membrane, hybridized with a 32P-labeled PLP ssDNA probe, and
exposed to an x-ray film for 2 min. C, The blot shown in B was exposed with a film for an
extended time (30 min). In B and C, arrowheads on the right of each indicate the expected
sizes for RT-PCR amplified DNA derived from PLP (687 bp) and DM-20 (582 bp) mRNA,
respectively.
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express DM-20 mRNA. Although our study clearly demonstrates
that NG2 oligodendrocyte precursors express no or little
DM-20 in vivo, our data do not exclude the possibility that there
are other oligodendrocyte precursors existing in CNS that are
capable of expressing DM-20 mRNA. In other words, it is possi-
ble that NG2-negative oligodendrocyte precursors express
DM-20 mRNA. Another possible explanation is that, although
DM-20 and its mRNA are expressed in myelinating oligodendro-
cytes, they are mainly synthesized in non-oligodendrocyte cells
during embryonic and early postnatal development. The latter
speculation is supported by the following findings: DM-20
mRNA is detected in multiple adult mouse organs, including
liver, heart, and spleen (Nadon et al., 1997), and in cultured C6
rat astroglioma and several neuronal cell lines (Ikenaka et al.,
1992); and premyelinating oligodendrocytes can be immuno-
stained with antibodies that recognize both PLP and DM-20
(Trapp et al., 1997).
In summary, using LCM in combination with RT-PCR, we
demonstrated that CNS NG2 cells express only PLP mRNA and
not the DM-20 isoform. These data offer new insights into the
gene expression of cells in the oligodendrocyte lineage. Our data
also demonstrate that LCM methodology is a powerful tool to
investigate the molecular characteristics of single antigenic posi-
tive cells in vivo.
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